Protocol | Published:

Generation of lung organoids from human pluripotent stem cells in vitro

Nature Protocolsvolume 14pages518540 (2019) | Download Citation


The lung epithelium is derived from the endodermal germ layer, which undergoes a complex series of endoderm–mesoderm-mediated signaling events to generate the final arborized network of conducting airways (bronchi, bronchioles) and gas-exchanging units (alveoli). These stages include endoderm induction, anterior–posterior and dorsal–ventral patterning, lung specification, lung budding, branching morphogenesis, and, finally, maturation. Here we describe a protocol that recapitulates several of these milestones in order to differentiate human pluripotent stem cells (hPSCs) into ventral–anterior foregut spheroids and further into two distinct types of organoids: human lung organoids and bud tip progenitor organoids. The resulting human lung organoids possess cell types and structures that resemble the bronchi/bronchioles of the developing human airway surrounded by lung mesenchyme and cells expressing alveolar-cell markers. The bud tip progenitor organoids possess a population of highly proliferative multipotent cells with in vitro multilineage differentiation potential and in vivo engraftment potential. Human lung organoids can be generated from hPSCs in 50–85 d, and bud tip progenitor organoids can be generated in 22 d. The two hPSC-derived models presented here have been benchmarked with human fetal tissue and found to be representative of human fetal-like tissue. The bud tip progenitor organoids are thus ideal for exploring epithelial fate decisions, while the human lung organoids can be used to model epithelial–mesenchymal cross-talk during human lung development. In addition to their applications in developmental biology, human lung organoids and bud tip progenitor organoids may be implemented in regenerative medicine, tissue engineering, and pharmaceutical safety and efficacy testing.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Data availability

Some of the data presented in the current study were generated for and published in previous reports. Original data used for figures in this paper are available at the following links: Fig. 2b–d (Dye et al.16),; Figs. 2e and 5g–j (Dye et al.15),; Figs. 2g–i and 5l–r (Miller et al.17),

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Key references using this protocol

Miller, A. J. et al. Stem Cell Rep. 10, 101–119 (2018):

Dye, B. R. et al. eLife 5, e19732 (2016):

Dye, B. R. et al. eLife 4, e05098 (2015):


  1. 1.

    Zorn, A. M. & Wells, J. M. Vertebrate endoderm development and organ formation. Annu. Rev. Cell Dev. Biol. 25, 221–251 (2009).

  2. 2.

    Chang, D. R. et al. Lung epithelial branching program antagonizes alveolar differentiation. Proc. Natl. Acad. Sci. USA 110, 18042–18051 (2013).

  3. 3.

    Rawlins, E. L. Lung epithelial progenitor cells: lessons from development. Proc. Am. Thorac. Soc. 5, 675–681 (2008).

  4. 4.

    Rawlins, E. L., Clark, C. P., Xue, Y. & Hogan, B. L. M. The Id2+ distal tip lung epithelium contains individual multipotent embryonic progenitor cells. Development 136, 3741–3745 (2009).

  5. 5.

    Spence, J. R. et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470, 105–109 (2011).

  6. 6.

    McCracken, K. W., Howell, J. C., Wells, J. M. & Spence, J. R. Generating human intestinal tissue from pluripotent stem cells in vitro. Nat. Protoc. 6, 1920–1928 (2011).

  7. 7.

    Múnera, J. O. et al. Differentiation of human pluripotent stem cells into colonic organoids via transient activation of BMP signaling. Cell Stem Cell 21, 51–64 (2017).

  8. 8.

    Tsai, Y.-H. et al. In vitro patterning of pluripotent stem cell-derived intestine recapitulates in vivo human development. Development 144, 1045–1055 (2017).

  9. 9.

    Hannan, N. R. F., Sampaziotis, F., Segeritz, C.-P., Hanley, N. A. & Vallier, L. Generation of distal airway epithelium from multipotent human foregut stem cells. Stem Cells Dev. 24, 1680–1690 (2015).

  10. 10.

    Hannan, N. R. F. et al. Generation of multipotent foregut stem cells from human pluripotent stem cells. Stem Cell Rep. 1, 293–306 (2013).

  11. 11.

    Longmire, T. A. et al. Efficient derivation of purified lung and thyroid progenitors from embryonic stem cells. Stem Cell 10, 398–411 (2012).

  12. 12.

    Huang, S. X. L. et al. Efficient generation of lung and airway epithelial cells from human pluripotent stem cells. Nat. Biotechnol. 32, 84–91 (2013).

  13. 13.

    Green, M. D. et al. Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells. Nat. Biotechnol. 29, 267–272 (2011).

  14. 14.

    Huang, S. X. L. et al. The in vitro generation of lung and airway progenitor cells from human pluripotent stem cells. Nat. Protoc. 10, 413–425 (2015).

  15. 15.

    Dye, B. R. et al. In vitro generation of human pluripotent stem cell derived lung organoids. Elife 4, e05098 (2015).

  16. 16.

    Dye, B. R. et al. A bioengineered niche promotes in vivo engraftment and maturation of pluripotent stem cell derived human lung organoids. Elife 5, e19732 (2016).

  17. 17.

    Miller, A. J. et al. In vitro induction and in vivo engraftment of lung bud tip progenitor cells derived from human pluripotent stem cells. Stem Cell Rep. 10, 101–119 (2018).

  18. 18.

    Cruz-Acuña, R. et al. Synthetic hydrogels for human intestinal organoid generation and colonic wound repair. Nat. Cell Biol. 19, 1326–1335 (2017).

  19. 19.

    Szenker-Ravi, E. et al. RSPO2 inhibition of RNF43 and ZNRF3 governs limb development independently of LGR4/5/6. Nature 557, 564–569 (2018).

  20. 20.

    Hill, D. R. et al. Bacterial colonization stimulates a complex physiological response in the immature human intestinal epithelium. Elife 6, e29132 (2017).

  21. 21.

    Hill, D. R., Huang, S., Tsai, Y.-H., Spence, J. R. & Young, V. B. Real-time measurement of epithelial barrier permeability in human intestinal organoids. J. Vis. Exp. (2017).

  22. 22.

    Perrin, S. Preclinical research: make mouse studies work. Nature 507, 423–425 (2014).

  23. 23.

    Ruggeri, B. A., Camp, F. & Miknyoczki, S. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery. Biochem. Pharmacol. 87, 150–161 (2014).

  24. 24.

    van der Laan, J. W., Chapin, R. E., Haenen, B., Jacobs, A. C. & Piersma, A. Testing strategies for embryo-fetal toxicity of human pharmaceuticals. Animal models vs. in vitro approaches: a workshop report. Regul. Toxicol. Pharmacol. 63, 115–123 (2012).

  25. 25.

    D’Amour, K. A. et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol. 23, 1534–1541 (2005).

  26. 26.

    Jacob, A. et al. Differentiation of human pluripotent stem cells into functional lung alveolar epithelial cells. Cell Stem Cell 21, 472–488 (2017).

  27. 27.

    McCauley, K. B. et al. Efficient derivation of functional human airway epithelium from pluripotent stem cells via temporal regulation of Wnt signaling. Cell Stem Cell 20, 844–857 (2017).

  28. 28.

    Chen, Y.-W. et al. A three-dimensional model of human lung development and disease from pluripotent stem cells. Nat. Cell Biol. 19, 542–549 (2017).

  29. 29.

    Gotoh, S. et al. Generation of alveolar epithelial spheroids via isolated progenitor cells from human pluripotent stem cells. Stem Cell Rep. 3, 394–403 (2014).

  30. 30.

    Konishi, S. et al. Directed induction of functional multi-ciliated cells in proximal airway epithelial spheroids from human pluripotent stem cells. Stem Cell Rep. 6, 18–25 (2016).

  31. 31.

    Hawkins, F. et al. Prospective isolation of NKX2-1-expressing human lung progenitors derived from pluripotent stem cells. J. Clin. Invest. 127, 2277–2294 (2017).

  32. 32.

    Wang, D., Haviland, D. L., Burns, A. R., Zsigmond, E. & Wetsel, R. A. A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 104, 4449–4454 (2007).

  33. 33.

    Firth, A. L. et al. Generation of multiciliated cells in functional airway epithelia from human induced pluripotent stem cells. Proc. Natl. Acad. Sci. USA 111, E1723–E1730 (2014).

  34. 34.

    Van Haute, L., De Block, G., Liebaers, I., Sermon, K. & De Rycke, M. Generation of lung epithelial-like tissue from human embryonic stem cells. Respir. Res. 10, 105 (2009).

  35. 35.

    Yamamoto, Y. et al. Long-term expansion of alveolar stem cells derived from human iPS cells in organoids. Nat. Methods 14, 1097–1106 (2017).

  36. 36.

    Nikolić, M. Z. & Rawlins, E. L. Lung organoids and their use to study cell-cell interaction. Curr. Pathobiol. Rep. 5, 223–231 (2017).

  37. 37.

    Miller, A. J. & Spence, J. R. In vitro models to study human lung development, disease and homeostasis. Physiology 32, 246–260 (2017).

  38. 38.

    Clevers, H. Modeling development and disease with organoids. Cell 165, 1586–1597 (2016).

  39. 39.

    Hannan, N. R. F., Segeritz, C.-P., Touboul, T. & Vallier, L. Production of hepatocyte-like cells from human pluripotent stem cells. Nat. Protoc. 8, 430–437 (2013).

  40. 40.

    Gjorevski, N. et al. Designer matrices for intestinal stem cell and organoid culture. Nature 539, 560–564 (2016).

  41. 41.

    Bartfeld, S. & Clevers, H. Organoids as model for infectious diseases: culture of human and murine stomach organoids and microinjection of Helicobacter pylori. J. Vis. Exp. 2015, e53359 (2015).

Download references


Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under award number R01HL119215 to J.R.S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Author information


  1. Program in Cell and Molecular Biology, University of Michigan Medical School, Ann Arbor, MI, USA

    • Alyssa J. Miller
    •  & Jason R. Spence
  2. Department of Biomedical Engineering, University of Michigan College of Engineering, Ann Arbor, MI, USA

    • Briana R. Dye
    • , Lonnie D. Shea
    •  & Jason R. Spence
  3. Division of Gastroenterology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA

    • Daysha Ferrer-Torres
    • , David R. Hill
    •  & Jason R. Spence
  4. Department of Cell Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands

    • Arend W. Overeem
  5. Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI, USA

    • Jason R. Spence
  6. Center for Organogenesis, University of Michigan Medical School, Ann Arbor, MI, USA

    • Jason R. Spence


  1. Search for Alyssa J. Miller in:

  2. Search for Briana R. Dye in:

  3. Search for Daysha Ferrer-Torres in:

  4. Search for David R. Hill in:

  5. Search for Arend W. Overeem in:

  6. Search for Lonnie D. Shea in:

  7. Search for Jason R. Spence in:


A.J.M., B.R.D. and J.R.S. conceived the studies. A.J.M., B.R.D., D.F.-T., D.R.H. and A.W.O. performed the experiments. A.J.M., B.R.D., D.F.-T., A.W.O., L.D.S. and J.R.S. analyzed the results. A.J.M. and J.R.S. wrote the manuscript. A.J.M., B.R.D., D.F.-T., A.W.O., D.R.H., L.D.S. and J.R.S. read and edited the manuscript.

Competing interests

J.R.S., B.R.D. and A.J.M. hold patents pertaining to the lung organoid technologies described. The other authors declare no competing interests.

Corresponding author

Correspondence to Jason R. Spence.

Supplementary information

About this article

Publication history




By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.